Fed Rate Hike Expectations Resurface as Inflation Surge Shifts Market Outlook Citi Raises Micron Technology Price Target to 840 Citing DRAM Price Surge New Tax Rules for Online Sellers and EV Buyers May Offer Savings This Season Wall Street Ends Higher as Healthcare Technology Lead Communication Services Lags Fresh US Military Strikes Raise Uncertainties for Iran Nuclear Diplomacy SEC Delays Plan Allowing for Crypto Versions of US Stocks Wells Fargo Q1 2026 Earnings Slight EPS Beat Amid Steady Operating Performance NEWTI Q1 2026 Earnings EPS Misses Estimates Revenue Not Disclosed RIGL Q1 2026 Earnings EPS Misses Estimates Amid Operational Updates BVN Q4 2025 Earnings Strong EPS Surprise Driven by Operational Gains LAR Q1 2026 Earnings Lithium Developer Misses EPS Estimates Shares Slide on Earnings Miss Seaport Entertainment Group Inc SEG Q1 2026 Earnings WiderThanExpected Loss Pressures Shares Rio Tinto RIO Slides 115 as Commodity Headwinds Persist Support at 10042 in Focus Cohen Steers Infrastructure Fund UTF Edges Higher as Infrastructure Demand Remains Steady SLR Investment Corp SLRC Edges Higher Near Support Level Technical Indicators Suggest Consolidation Summit State Bank SSBI Holds Steady Navigating a Narrow Trading Band Sunstone Hotel Investors SHO Rises 193 as Hospitality Sector Shows Signs of Stabilization TD Cowen Adjusts Sea Limited Price Target While Maintaining Hold Rating LendingClub LC Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Lower Sportradar Group SRAD Edges Higher Holding Above Key Support Amid Modest Volume HBANM Q1 2026 Earnings Preferred Dividend Coverage Falls Short of Expectations ASRV Q1 2026 Earnings Stable EPS at 011 Amidst Flat Market Response MSFT Q1 2026 Earnings Solid EPS Beat Offsets Modest Revenue Headwinds AEM Q1 2026 Earnings Earnings Beat Expectations Amid Mixed Market Sentiment LAZ Q1 2026 Earnings EPS Falls Short of Estimates as Stock Inches Higher SFBS Q1 2026 Earnings EPS Slightly Beats Estimates Stock Declines Marginally NewAmsterdam Pharma NAMS Q1 2026 Earnings Narrowerthanexpected loss as biotech advances pipeline